Sucampo Appoints Andrew Smith, FCMA, CGMA as CFO
January 30, 2015 16:02 ET
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., Jan. 30, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced the appointment of Andrew Smith, FCMA, CGMA...
AMITIZA(R) (lubiprostone) Mutual Recognition Procedure Closes With Recommendation for Approval in European Countries
January 30, 2015 06:45 ET
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., Jan. 30, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced the successful completion of the European...
Robert J. Spiegel, M.D., FACP Joins Sucampo's Board of Directors
January 21, 2015 06:45 ET
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., Jan. 21, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that Robert J. Spiegel, M.D., FACP has...
Sucampo Announces Acceptance of New Drug Submission for AMITIZA(R) (lubiprostone) by Health Canada
December 30, 2014 17:00 ET
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., Dec. 30, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that Health Canada has accepted the...
Sucampo Files Patent Infringement Lawsuit Against Dr. Reddy's
November 12, 2014 17:31 ET
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., Nov. 12, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Nasdaq:SCMP), a global biopharmaceutical company, today announced that Sucampo, R-Tech Ueno, Ltd., Takeda Pharmaceutical...
Sucampo Announces Third Quarter 2014 Financial Results
November 06, 2014 06:45 ET
|
Sucampo Pharmaceuticals Inc
Strong Revenue and Sales Growth for AMITIZA
Raises 2014 Earnings Guidance, Excluding Special Items
CEO Peter Greenleaf to Provide Update on Significant Progress Against Strategic Plan...
Sucampo Solidifies Leadership Team With Additions of CSO and Heads of Business Development, Regulatory Affairs
October 23, 2014 16:02 ET
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., Oct. 23, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced three executive appointments that expand and...
Takeda and Sucampo Enter Into Global Licensing Agreement for AMITIZA(R) (lubiprostone)
October 21, 2014 18:00 ET
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., October 21, 2014 and OSAKA, Japan, October 22, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, and Takeda...
Sucampo Announces Extension of AMITIZA(R) (lubiprostone) License and Collaboration Agreement With Takeda
October 14, 2014 06:45 ET
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., Oct. 14, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it signed on October 9, 2014 an...
Sucampo Reports Second Quarter 2014 Financial Results and Corporate Update
August 05, 2014 06:15 ET
|
Sucampo Pharmaceuticals Inc
Positive Net Income Driven by Strong Revenue Growth in Product Royalty and Product Sales
CEO Peter Greenleaf to Discuss Results of Sucampo's Strategic Review
Company Raises Full Year 2014...